Status:

COMPLETED

Boiled Peanut Oral Immunotherapy

Lead Sponsor:

Alton Melton

Collaborating Sponsors:

The Cleveland Clinic

Conditions:

Peanut Hypersensitivity

Eligibility:

All Genders

1-16 years

Phase:

PHASE1

Brief Summary

Prospective Phase 1 clinical trial providing proof of concept data on boiled peanut oral immunotherapy (OIT) for the treatment of peanut allergy in children. The investigators hypothesize that the pro...

Detailed Description

Oral Immunotherapy will be administered utilizing a powder derived from boiled peanuts. Treatment will begin with an initial escalation day in which dosing is begun at 0.1 mg peanut protein and escala...

Eligibility Criteria

Inclusion

  • Age 1-16 years
  • History of immediate hypersensitivity reaction to peanut
  • Evidence of IgE mediated peanut hypersensitivity within a 12 month period of study enrollment
  • SPT with wheal/flare of at least 3 x 6 mm and/or Peanut specific IgE \>0.35 kU/L

Exclusion

  • History of life threatening peanut anaphylaxis
  • Asthma requiring more than medium dose ICS
  • Prior participation in oral immunotherapy, sublingual immunotherapy or epicutaneous immunotherapy
  • Oat allergy
  • Cardiovascular Disease
  • Use of beta-blockers (oral), angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or calcium channel blockers
  • Use of steroid medications in the following manners:
  • Daily oral steroid dosing for greater than 1 month during the past year
  • Burst or steroid course in the past 3 month before inclusion
  • Greater than 2 bursts oral steroid courses in the past year of at least 1 week duration
  • Pregnancy or lactation
  • Eosinophilic Gastrointestinal Disease
  • History of food protein-induced enterocolitis
  • History of developmental delay or speech delay that precludes age- appropriate communication, in the opinion of the investigator

Key Trial Info

Start Date :

November 5 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 20 2021

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT04090203

Start Date

November 5 2019

End Date

May 20 2021

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195